The development of head and neck cancer is increasingly linked to HPV infection, which is a sexually transmitted disease. Oropharyngeal cancer is a type of head and neck cancer that is associated with preconceptions regarding ...
Jul 14, 2023
0
3
For women over the age of 65 who have never had a high-risk human papillomavirus (HPV) test, a "catch up" HPV screening intervention may improve cervical cancer prevention by detecting more cervical pre-cancer lesions as ...
Jul 6, 2023
0
37
Tobacco smoking and human papillomavirus (HPV) are both well-known risk factors for head and neck cancer, but there is ample evidence to show they can interact to further increase the risk of contracting the disease, according ...
Jul 3, 2023
0
75
The HPV vaccination program in England is moving to a single-dose schedule from September 2023, the UK Health Security Agency (UKHSA) has announced.
Jun 21, 2023
0
1
Researchers at the UNC Gillings School of Global Public Health and UNC Lineberger Comprehensive Cancer Center have found that mailing human papillomavirus (HPV) self-collection tests and offering assistance to book in-clinic ...
May 11, 2023
0
63
Over the past two decades, there has been a rapid increase in throat cancer in the west, to the extent that some have called it an epidemic. This has been due to a large rise in a specific type of throat cancer called oropharyngeal ...
Apr 26, 2023
0
8
In 2020 the World Health Organization introduced a plan to eliminate cervical cancer as a public health threat by 2030. The first step towards this goal is to have 90% of girls fully vaccinated against human papillomavirus ...
Apr 10, 2023
0
2
A study analyzing 36 years of cancer data has revealed a rising incidence and a worsening death rate for oral cancer in Queensland.
Apr 6, 2023
0
18
Human papillomavirus (HPV)-negative head and neck squamous cell carcinoma (HNSCC) and lung cancer can have disruptive mutations in TP53 and/or CDKN2A tumor suppressor genes, which are associated with poor patient survival.
Apr 5, 2023
0
7
A new combination drug treatment has shown promising results in patients with pan-refractory, recurrent/metastatic head and neck cancer, according to a study published today in the Journal of Clinical Oncology.
Mar 28, 2023
0
2
